NASDAQ:CERE Cerevel Therapeutics (CERE) Stock Chart & Stock Price History $20.36 +0.09 (+0.44%) (As of 10/4/2023 ET) Add Compare Share Share Today's Range$19.59▼$20.5050-Day Range$20.26▼$30.6552-Week Range$19.59▼$35.98Volume587,972 shsAverage Volume619,369 shsMarket Capitalization$3.21 billionP/E RatioN/ADividend YieldN/APrice Target$33.90 ChartProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media Cerevel Therapeutics Stock Price Performance5 Day Performance-6.73%1 Month Performance-13.95%3 Month Performance-35.26%6 Month Performance-16.45%Year-To-Date Performance-35.45%1 Year Performance-32.45% Receive CERE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerevel Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address CERE Stock Chart for Wednesday, October, 4, 2023 CERE Chart by TradingView Cerevel Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/04/2023$20.27$20.36+0.44%$20.50$19.59587,972 shs$3.21 billion10/03/2023$20.89$20.27-2.97%$20.84$20.22491,891 shs$3.19 billion10/02/2023$21.83$20.89-4.31%$21.81$20.68735,153 shs$3.29 billion09/29/2023$22.17$21.83-1.53%$22.43$21.71833,700 shs$3.44 billion09/28/2023$21.05$22.17+5.32%$22.24$21.51745,728 shs$3.49 billion09/27/2023$20.56$21.05+2.38%$21.19$20.56673,119 shs$3.32 billion Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 09/26/2023$20.35$20.56+1.03%$20.95$20.321.02 million shs$3.24 billion09/25/2023$20.26$20.35+0.44%$20.42$19.85806,648 shs$3.20 billion09/22/2023$20.63$20.26-1.79%$20.65$19.97832,916 shs$3.19 billion09/21/2023$20.80$20.63-0.82%$21.15$20.48772,818 shs$3.25 billion09/20/2023$21.21$20.80-1.93%$21.31$20.71834,698 shs$3.28 billion09/19/2023$21.84$21.21-2.88%$21.98$21.06985,409 shs$3.34 billion09/18/2023$22.65$21.84-3.58%$22.92$21.77574,474 shs$3.44 billion09/15/2023$22.33$22.65+1.43%$23.00$21.961.45 million shs$3.57 billion09/14/2023$22.60$22.33-1.19%$23.03$22.25917,871 shs$3.52 billion09/13/2023$23.45$22.60-3.62%$23.53$22.55600,592 shs$3.56 billion09/12/2023$24.04$23.45-2.45%$23.98$23.35590,832 shs$3.69 billion09/11/2023$24.18$24.04-0.58%$24.51$23.99493,609 shs$3.79 billion09/08/2023$24.03$24.18+0.62%$24.43$24.00497,249 shs$3.81 billion09/07/2023$24.26$24.03-0.95%$24.32$23.97688,256 shs$3.78 billion09/06/2023$24.11$24.26+0.62%$24.40$23.66531,088 shs$3.82 billion09/05/2023$23.66$24.11+1.90%$24.46$23.33750,353 shs$3.80 billion09/04/2023$23.66$23.66$24.16$23.60434,200 shs$3.73 billion09/01/2023$23.70$23.66-0.17%$24.16$23.60434,224 shs$3.73 billion08/31/2023$23.93$23.70-0.96%$24.06$23.61508,217 shs$3.73 billion08/30/2023$23.50$23.93+1.83%$24.09$23.44515,178 shs$3.77 billion08/29/2023$23.00$23.50+2.17%$23.77$22.99386,632 shs$3.70 billion08/28/2023$22.89$23.00+0.48%$23.44$22.87327,368 shs$3.62 billion08/25/2023$22.43$22.89+2.05%$23.33$22.43404,479 shs$3.60 billion08/24/2023$22.86$22.43-1.88%$22.96$22.20413,542 shs$3.53 billion08/23/2023$22.12$22.86+3.35%$23.06$22.19579,268 shs$3.60 billion08/22/2023$21.64$22.12+2.22%$22.29$21.64443,720 shs$3.48 billion08/21/2023$20.94$21.64+3.34%$21.97$20.85519,617 shs$3.41 billion08/18/2023$21.03$20.94-0.43%$21.44$20.71579,812 shs$3.30 billion08/17/2023$21.39$21.03-1.68%$21.52$20.89481,669 shs$3.31 billion08/16/2023$21.76$21.39-1.70%$21.97$21.09679,469 shs$3.37 billion08/15/2023$22.00$21.76-1.09%$22.16$21.49539,452 shs$3.43 billion08/14/2023$22.04$22.00-0.18%$22.15$21.08684,156 shs$3.46 billion08/11/2023$21.99$22.04+0.23%$22.36$21.78559,936 shs$3.46 billion08/10/2023$21.91$21.99+0.37%$22.52$21.72601,042 shs$3.45 billion08/09/2023$21.76$21.91+0.69%$22.14$21.62724,499 shs$3.44 billion08/08/2023$20.55$21.76+5.89%$23.04$21.581.80 million shs$3.41 billion08/07/2023$22.47$20.55-8.54%$22.21$20.491.96 million shs$3.22 billion08/04/2023$23.76$22.47-5.43%$23.76$22.031.85 million shs$3.52 billion08/03/2023$26.33$23.76-9.76%$26.11$23.672.37 million shs$3.73 billion08/02/2023$30.65$26.33-14.09%$29.77$24.992.63 million shs$4.13 billion08/01/2023$30.59$30.65+0.20%$30.70$30.13292,835 shs$4.81 billion07/31/2023$30.47$30.59+0.39%$30.66$30.15298,470 shs$4.80 billion07/28/2023$30.03$30.47+1.47%$30.85$29.70356,952 shs$4.78 billion07/27/2023$29.94$30.03+0.30%$30.27$29.56283,631 shs$4.71 billion07/26/2023$30.73$29.94-2.57%$30.84$29.89291,835 shs$4.70 billion07/25/2023$30.63$30.73+0.33%$30.95$30.32460,546 shs$4.82 billion07/24/2023$29.49$30.63+3.87%$30.81$29.47522,644 shs$4.80 billion07/21/2023$29.24$29.49+0.85%$29.71$29.17335,441 shs$4.62 billion07/20/2023$29.11$29.24+0.45%$29.97$28.98323,972 shs$4.59 billion07/19/2023$29.26$29.11-0.51%$29.64$28.86377,665 shs$4.57 billion07/18/2023$29.68$29.26-1.42%$29.97$29.23590,728 shs$4.59 billion07/17/2023$30.18$29.68-1.66%$30.59$29.67565,119 shs$4.65 billion07/14/2023$30.08$30.18+0.33%$30.38$29.53372,786 shs$4.73 billion07/13/2023$30.40$30.08-1.05%$30.85$30.07373,878 shs$4.72 billion07/12/2023$30.20$30.40+0.66%$30.70$30.15743,848 shs$4.77 billion07/11/2023$30.59$30.20-1.27%$30.48$29.67548,365 shs$4.74 billion07/10/2023$30.16$30.59+1.43%$30.79$29.88576,418 shs$4.80 billion07/07/2023$31.60$30.16-4.56%$32.04$30.07482,737 shs$4.73 billion07/06/2023$31.91$31.60-0.97%$31.79$31.26342,905 shs$4.96 billion07/05/2023$31.45$31.91+1.46%$31.92$31.19368,479 shs$5.00 billion07/04/2023$31.45$31.45$31.98$31.11198,508 shs$4.93 billion07/03/2023$31.79$31.45-1.07%$31.98$31.11198,499 shs$4.93 billion Related Companies: Corcept Therapeutics Stock Chart Axsome Therapeutics Stock Chart Blueprint Medicines Stock Chart MoonLake Immunotherapeutics Stock Chart Evotec Stock Chart Indivior Stock Chart Bausch Health Companies Stock Chart Amicus Therapeutics Stock Chart Prestige Consumer Healthcare Stock Chart Cytokinetics Stock Chart Receive CERE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cerevel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CERE) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerevel Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.